RT Journal Article
SR Electronic
T1 COVID-19 impact on consecutive neurological patients admitted to the emergency department
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.23.20110650
DO 10.1101/2020.05.23.20110650
A1 Pilotto, Andrea
A1 Benussi, Alberto
A1 Libri, Ilenia
A1 Masciocchi, Stefano
A1 Poli, Loris
A1 Premi, Enrico
A1 Alberici, Antonella
A1 Baldelli, Enrico
A1 Bonacina, Sonia
A1 Brambilla, Laura
A1 Benini, Matteo
A1 Caratozzolo, Salvatore
A1 Cortinovis, Matteo
A1 Costa, Angelo
A1 Piccinelli, Stefano Cotti
A1 Cottini, Elisabetta
A1 Cristillo, Viviana
A1 Delrio, Ilenia
A1 Filosto, Massimiliano
A1 Gamba, Massimo
A1 Gazzina, Stefano
A1 Gilberti, Nicola
A1 Gipponi, Stefano
A1 Giunta, Marcello
A1 Imarisio, Alberto
A1 Liberini, Paolo
A1 Locatelli, Martina
A1 Cola, Francesca Schiano di
A1 Rao, Renata
A1 Risi, Barbara
A1 Rozzini, Luca
A1 Scalvini, Andrea
A1 Vergani, Veronica
A1 Volonghi, Irene
A1 Zoppi, Nicola
A1 Borroni, Barbara
A1 Magoni, Mauro
A1 Leonardi, Matilde
A1 Zanusso, Gianluigi
A1 Ferrari, Sergio
A1 Mariotto, Sara
A1 Pezzini, Alessandro
A1 Gasparotti, Roberto
A1 Paolillo, Ciro
A1 Padovani, Alessandro
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.23.20110650.abstract
AB Objective Aim of this study was to analyse the impact of COVID-19 on clinical and laboratory findings and outcome of neurological patients consecutively admitted to the emergency department (ED) of a tertiary hub center.Methods All adult patients consecutively admitted to the ED for neurological manifestations from February 20th through April 30th 2020 at Spedali Civili of Brescia entered the study. Demographic, clinical, and laboratory data were extracted from medical records and compared between patients with and without COVID-19.Results Out of 505 consecutively patients evaluated at ED with neurological symptoms, 147 (29.1%) tested positive for SARS-CoV-2. These patients displayed at triage higher values of CRP, AST, ALT, and fibrinogen but not lymphopenia (p<0.05). They were older (73.1 ± 12.4 vs 65.1 ± 18.9 years, p=0.001) had higher frequency of stroke (34.7% vs 29.3%), encephalitis/meningitis (9.5% vs 1.9%) and delirium (16.3% vs 5.0%). Compared to patients without COVID, they were more frequently hospitalized (91.2% vs 69.3%, p<0.0001) and showed higher mortality rates (29.7% vs 1.8%, p<0.0.001) and discharge disability, independently from age.Conclusions COVID-19 impacts on clinical presentation of neurological disorders, with higher frequency of stroke, encephalitis and delirium, and was strongly associated with increased hospitalisation, mortality and disability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee of ASST Spedali Civili di Brescia Hospital (NP 4067, approved 08.05.2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are made available from authors upon reasonable request